The Food and Drug Administration announced that hormone therapies for menopause will no longer need a black box warning about ...

The FDA put a black box warning on estrogen products for hormone therapy in 2003, and it’s stayed there ever since. And women ...

FDA remove boxed warnings on hormone therapy for menopause after review finds prior risks outdated, updating labels to reflect current science.

The benefits of hormone replacement have been underappreciated, Dr. Marty Makary, the agency’s commissioner, said on Monday. Critics described evidence for the change as insufficient.

In a pivotal move, the US Food and Drug Administration has changed // done away with the lengthy black box warning on many hormone treatments for women with menopause symptoms.

The decision aims to improve access to HRT by removing warnings about cardiovascular disease, breast cancer, and probable dementia. HHS has initiated removal of black box warnings on hormone ...

Hormone-based drugs used to treat menopause symptoms will no longer carry a warning label about stroke, heart attack, ...